Muhunthan Thillai MD, co-founder and CEO, Qureight, commented: “Rebecca’s experience, expertise and people-centric leadership ...

Lundbeck A/S has announced encouraging new data from the intravenous part of its phase 2b PROCEED trial, showing that investigational migraine prevention treatment bocunebart achieved its primary ...

The European Life Sciences Coalition has been launched in Brussels with the aim of strengthening Europe’s life sciences and ...

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence for durvalumab, ...

In oncology care, clinical success is defined primarily by time: months or years of survival. Yet for patients living with ...

Bioxytran has reported positive results from its completed phase 2 trial of ProLectin‑M, showing rapid and sustained viral clearance in subjects with laboratory‑confirmed acute viral infection. The ...

THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex acquiring rights to develop and commercialise two drug candidates across multiple ...

Marketing-centric engagement, designed for lower-complexity markets where scale and awareness are priorities. This model ...

Serac Healthcare has received fast track designation from the US Food and Drug Administration for 99mTc‑maraciclatide, a SPECT‑CT imaging agent intended for the visualisation of inflammation in ...

Breye Therapeutics has reported promising early clinical findings for its lead oral therapy danegaptide, following a presentation at the Angiogenesis, Exudation and Degeneration 2026 symposium.

Ahmed Moussa has been appointed as the new Sanofi Country Lead for the UK & Ireland, taking over from Rippon Ubhi. In his new ...

emc receives over 40 million visits per year, with 72% of HCPs stating this resource as their first-choice source of medicines information. For a deeper look at the survey findings and its ...